Ozanimod shows efficacy in two-year study extension

Zeposia is an oral sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Ozanimod shows efficacy in two-year study extension

Post by MSUK » Mon Sep 26, 2016 3:22 am

Results from the extension period of a Phase II trial, assessing Ozanimod as a potential treatment for relapsing-remitting multiple sclerosis, showed that the drug can effectively and safely improve clinical measures of RRMS after two years of treatment...Read more - http://www.ms-uk.org/ozanimod-shows-eff ... ion-260916
MS-UK - http://www.ms-uk.org/

Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “Zeposia (Ozanimod)”